Eli Lilly's Winning Week

Eli Lilly, a big name in medicine, just got more good news. The company already has a leading diabetes drug. Now, two more of its treatments show promise.

First, the Food and Drug Administration (FDA) looks at a new drug. This drug could help people with a tough lung disease. It helps protect cells. This review brings hope for many patients. The FDA will decide by June 2025.

Next, the European Union (EU) gave a fast pass to another Eli Lilly drug. This drug fights a common type of lung cancer. The EU wants to speed up its review. This means patients there could get help sooner. Eli Lilly keeps working to find new ways to treat serious illnesses.

Source: CNBC